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ABSTRACT: Vasopressin (AVP) is an ancient molecule of the salt-
water homeostasis. On the other hand, in the brain AVP can be 
found in many regions, where it has a prominent role in the 
regulation of stress and stress related diseases, too. During acute 
stress AVP regulates the adrenocorticotropin secretion in a time and 
stressor specific manner. Its role seems to be especially critical 
during the perinatal period. Despite earlier theories, during chronic 
stress the role of AVP has never been highlighted. AVP seems to be 
also responsible for our mood. Its high level is accompanied by 
higher level of anxiety and depression. Pharmacological intervention 
of the AVP secretion could influence not only the salt-water 
homeostasis, but might have strong impact on our stress state and 
behaviour. 
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Introduction 
Arginine vasopressin (AVP), also known as antidiuretic hormone, is a 
peptide hormone. Its main source in the blood is the neuronal lobe 
of the hypophysis (NL). The hormones of the NL are not synthesised 
in the gland itself, but in the magnocellular cells of the supraopticus 
(SON) and paraventricular (PVN) hypothalamic nuclei. The brain also 
contains several populations of AVP containing smaller, parvocellular 
neurons whose projections remain within the brain (1).  
 
Role of vasopressin in physiological processes 
The fundamental function of AVP is to conserve body water when 
body is threatened with dehydration. Through V2 receptors in the 
renal collecting duct, AVP induces translocation of aquaporin-2 water 
channels to the apical plasma membrane, allowing water resorption. 
Through V1a receptors AVP can cause contraction of almost any 
smooth muscle (2). Due to vasoconstriction AVP increases the blood 
pressure. This effect appears small in healthy individuals; however it 
becomes important during hypovolemic shock.  
The behavior of an animal is influenced by a central circadian clock 
in the suprachiasmatic nucleus. AVP is the only substance to date 
that has been shown to be released in a circadian rhythm to the 
cerebrospinal fluid. AVP is important in the regulation of social 
interactions (3). In knockout (KO) mice a prominent role of V1b 
receptors were found in agression. In respect to social bonds, 
monogamous voles have less AVP in their lateral septum and more 
in their amygdala compared to non-monogamous voles. There is a 
clear correlation of AVP and parental behavior of voles as well. With 
strong connection to its role in social interactions the AVP has a role 
in social memory, too. AVP in the olfactory bulb plays a prominent 
role in the olfactory memory formation, thereby influencing social 
recognition. Several studies indicate a general beneficial effect of 
AVP administration on spatial memory, too.  
 
Stress 
Maintenance of the homeostasis in a constantly changing 
environment is a fundamental process of life. Stress is defined as 
anything that throws the body out of homeostatic balance. Already 
Hans Selye, the father of stress concept discovered that the basis of 
the adaptation is the hypothalamo-pituitary-adrenal (HPA) axis (4).  
 
HPA axis and vasopressin 
The neurons of the magnocellular PVN and SON project through the 
median eminence (ME) to the NL being involved in the water 
balance. This AVP pool might have an effect on the regulation of the 
adrenocorticotropin (ACTH) secretion as well, especially during 
osmotic stimuli (5) (Fig.1). The more medially situated parvocellular 
PVN contains AVP in colocalization with corticotropin-releasing 
hormone (CRH) and through a release into the portal vasculature at 
the ME regulate ACTH secretion (6). AVP may cause ACTH secretion 
through mobilization of NL CRH and/or AVP might have a local 
action on the control of anterior lobe (AL) microcirculation as well 
(7). ACTH, through the systemic circulation, induces the secretion of 
glucocorticoids (in rodents mainly corticosterone) from the adrenal 
cortex. Regulation of corticosterone secretion is critical for life and is 
necessary for the mammalian stress response. AVP reaches the 
adrenal gland through general circulation and also from the adrenal 
medulla, thereby having a direct impact on corticosterone secretion. 
AVP may also modulate responses to stress by expression and 



































Several animal studies support the role of AVP in acute HPA axis 
regulation. Intraventricular administration of AVP antiserum blocked 
the release of ACTH induced by electrical stimulation of the PVN. 
Additionally the pretreatment of rats with AVP antiserum inhibited 
the ACTH response to restraint, formalin and ether stress without 
affecting the resting levels (9). The resting ACTH and corticosterone 
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plasma levels of the natural AVP KO rat line, the Brattleboro rats 
appear to be normal, too. Their HPA response to acute stress was 
highly stressor specific with at least a tendency of reduced ACTH 
elevations in most case. Two Wistar rat lines, selectively bred for 
high- (HAB) and low-anxiety-related behavior (LAB) in the elevated 
plus maze (EPM) test were described with lower AVP 
immunoreactivity and AVP mRNA content in the PVN of LAB rats (3). 
The ACTH elevation was diminished in LAB rats after EPM.  
AVP may influence the HPA axis through V1b receptors located 
mainly in the AL. The lack of V1b receptor did not influence the 
resting ACTH and corticosterone levels. Restraint or aggressive 
contact-induced secretion of ACTH and corticosterone was also 
similar in wild type and V1bR KO mice, but the hypoglycemia-, 
lipopolysaccharide-, forced swim- and ethanol-intoxication-induced 
elevations was significantly diminished. The selective, nonpeptide 
V1b receptor antagonist (SSR149415) was able to diminish the 
restraint-induced ACTH increase by 50% and inhibited the response 
to ether exposure but failed to inhibit the HPA axis during forced 
swimming (FS).  
Taken together AVP participates in acute stress-induced HPA axis 
regulation, although the effect of AVP is limited and might depend 
upon the situation/test (stress-dependent role of AVP). AVP might 
be responsible for the recovery of the corticosterone secretion to the 
basal level after acute stimulation (time-dependent role of AVP) 
(10). 
Chronic stress 
Enhanced release of AVP during chronic stress and the relative 
resistance to feedback inhibition of ACTH release stimulated by AVP 
has been proposed to explain how chronic stressful stimulation 
results in steadily high adrenocortical hormone levels (6).  
Previous data with AVP-deficient Brattleboro rats suggested that the 
lack of AVP did not affect the development of the chronic 
hyperactivity of the HPA-axis during 2 weeks repeated restraint, 
strepozotocin induced diabetes mellitus or chronic morphine 
treatment (11). The prolonged (5 weeks) chronic mild stress-
induced HPA axis activation was not affected by the lack of AVP in 
Brattleboro rats, too. 
Moreover, there were no differences in the HPA axis activation of 
V1b receptor KO and wild type mice after chronic restraint (9). 
Recent studies in repeatedly restrained rats show only minor effects 
of SSR149415 on ACTH responses to a novel stress. The non-
selective V1 antagonist was unable to inhibit ACTH responses to 
hypertonic saline injection in repeatedly stressed rats, too.  
Taken together in the absence of AVP ACTH secretion is sufficient to 
elicit full adrenal glucocorticoid responses. In addition, AVP does not 




In rats the HPA-axis is already functional in late gestation. However, 
plasma levels decrease dramatically during the first two postnatal 
days and remain low until postnatal day 14 (12). During this period 
the response of the HPA-axis to stressful stimuli is markedly reduced 
(13). It was assumed that the diminished production and/or 
transport of hypothalamic secretagogues may also decrease 
corticosterone stress responses. Indeed, the glucocorticoid 
regulation of hypothalamic CRH gene expression is not mature in the 
stress hyporesponsive period. In contrast, the regulation of 
hypothalamic AVP gene expression matures very early (14). Passive 
immunization to AVP in 8-day-old rats prevented the hypoglycemia-
induced ACTH-rise without affecting the basal levels, while the CRH 
immunization was ineffective. One can hypothesize that the 
involvement of AVP is stressor specific. However, this assumption is 
unlikely, as AVP-deficiency in Brattleboro rat pups abolished the 
ACTH response to widely different stressors (15). The data from 
genetic models were also repeated by SSR149415 with the same 
results. An unexpected finding of these experiments were the 
dissociation of the ACTH and corticosterone secretion, as AVP-
deficiency abolished only the stressor-induced ACTH enhancement, 
but the serum corticosterone elevations remained intact. 
We can conclude that AVP is the main regulator of the ACTH 
secretion during the perinatal period. However, ACTH rise does not 
precede the corticosterone elevations. 
Stress related disorders and vasopressin 
Anxiety and depression are behavioral states associated with stress. 
Overactivation of the HPA axis is the most consistently described 
biological abnormality in depression (16). Patient with major 
depression have significantly elevated plasma and hypothalamic AVP 
levels compared to healthy controls.  
The widely used test of depression, the FS induces a significant 
increase in AVP release in both the SON and PVN and also in the 
septum and amygdala (3). The lack of AVP in Brattleboro rats 
resulted in a less anxious state on the EPM and a less depressive 
state in the FS (2, 3). LAB rats, selected upon their behavior on the 
EPM test, show similar behavior profile and AVP “deficiency” to 
Brattleboro rats further supporting the role of AVP in anxiety and 
depression. Administration of V1a receptor antagonist decreases the 
anxiety- and depressive-like behavior in HAB rats. Male V1a receptor 
KO mice display significantly less anxiety-related behavior than 
wildtype on a variety of tasks. Interestingly V1b receptor KO mice do 
not have an anxiolitic phenotype.  
The presented results confirmed the strong correlation between AVP 
and anxiety and depressive-like behaviors in animal models. The fact 
that V1b antagonist is effective even after hypophysectomy suggest 
a separation between HPA axis regulation and behavior. 
 
Conclusion 
During the latest decades it turned out that AVP has a much broader 
effect than just to regulate the salt-water homeostasis. Based upon 
the results presented above AVP is a key regulator of the stress- axis 
(Fig.1) and has a strong impact on the stress-related behavior, as 
well. Nowadays AVP agonists and antagonists are widely used in 
clinical praxis from resuscitation till the treatment of hyponatremia, 
heamorrhagic shock etc (17). We should be aware that these 
pharmacological interventions could influence not only the salt-water 




The authors are grateful to the OTKA (Budapest, Hungary) and 
Indian National Science Academy (New Delhi, India) for their 
financial and moral support. 
 
References 
Buijs RM. Intra- and extrahypothalamic vasopressin and oxytocin 
pathways in the rat. Pathways to the limbic system, medulla 
oblongata and spinal cord. Cell Tissue Res, 192:423-35, 1978 
Zelena D. The Role of Vasopressin in Affective Disorders: Possible 
Targets of Intervention. Central Nervous System Agents in 
Medicinal Chemistry, 8:275-285, 2008 
Frank E and Landgraf R. The vasopressin system--from antidiuresis 
to psychopathology. Eur J Pharmacol, 583:226-42, 2008 
Selye H and Fortier C. Adaptive reactions to stress. Res Publ Assoc 
Res Nerv Ment Dis, 29:3-18, 1949 
Wotjak CT, Ludwig M, Ebner K, Russell JA, Singewald N, Landgraf R 
and Engelmann M. Vasopressin from hypothalamic 
magnocellular neurons has opposite actions at the 
adenohypophysis and in the supraoptic nucleus on ACTH 
secretion. Eur J Neurosci, 16:477-85, 2002 
Aguilera G. Regulation of pituitary ACTH secretion during chronic 
stress. Front Neuroendocrinol, 15:321-50, 1994 
Zelena D and Jain SK. Oxytocin and Vasopressin in Stress and 
Stress-Related Diseases: Yin/Yang Counterpairs or Substitutes? 
in Handbook of Oxytocin Research, Editor: Hugo Jastrow and 
Daniela Feuerbach,, 1-34, 2009 
Russell JA and Walley KR. Vasopressin and its immune effects in 
septic shock. J Innate Immun, 2:446-60, 2010 
Zelena D, Domokos A, Jain SK, Jankord R and Filaretova L. The 
stimuli-specific role of vasopressin in the hypothalamus-
pituitary-adrenal axis response to stress. J Endocrinol, 202:263-
78, 2009 
Zelena D, Langnaese K, Domokos A, Pinter O, Landgraf R, Makara 
GB and Engelmann M. Vasopressin administration into the 
paraventricular nucleus normalizes plasma oxytocin and 
corticosterone levels in Brattleboro rats. Endocrinology, 
150:2791-8, 2009 
J Exp Sci Vol. 1, Issue 9, Pages 01-03 [2010] 
 
 
Varga J, Domokos A, Barna I, Jankord R, Bagdy G and Zelena D. 
Lack of vasopressin does not prevent the behavioural and 
endocrine changes induced by chronic unpredictable stress. 
Brain Res Bull, 2010 
Walker CD, Perrin M, Vale W and Rivier C. Ontogeny of the stress 
response in the rat: role of the pituitary and the hypothalamus. 
Endocrinology, 118:1445-51, 1986 
Sapolsky RM and Meaney MJ. Maturation of the adrenocortical stress 
response: neuroendocrine control mechanisms and the stress 
hyporesponsive period. Brain Res, 396:64-76, 1986 
Muret L, Priou A, Oliver C and Grino M. Stimulation of 
adrenocorticotropin secretion by insulin-induced hypoglycemia 
in the developing rat involves arginine vasopressin but not 
corticotropin-releasing factor. Endocrinology, 130:2725-32, 
1992 
Zelena D, Domokos A, Barna I, Mergl Z, Haller J and Makara GB. 
Control of the hypothalamo-pituitary-adrenal axis in the 
neonatal period: adrenocorticotropin and corticosterone stress 
responses dissociate in vasopressin-deficient brattleboro rats. 
Endocrinology, 149:2576-83, 2008 
Scott LV and Dinan TG. Vasopressin as a target for antidepressant 
development: an assessment of the available evidence. J Affect 
Disord, 72:113-24, 2002 
Treschan TA and Peters J. The vasopressin system: physiology and 
clinical strategies. Anesthesiology, 105:599-612; quiz 639-40, 
2006.
 
